The Rise of Digital Therapeutics

How Digital Therapies Can Help Reimagine Care and Treatment

About This Report
Digital therapeutics (DTx) are becoming more prominent offerings in healthcare. Questions are now arising around which stakeholders will pay for these products and how accessible they’ll be for patients.
Table of Contents

Executive Summary

Digital therapeutics (DTx) are an emerging category of evidence-based technologies that could disrupt drug development and disease treatment. DTx products have not hit the mainstream and will need to meet a high standard of clinical validation that separates these solutions from the sea of available digital health tools and apps on the market.


  1. How has the pandemic advanced DTx? 
  2. Why should payers, employers, providers, and drug developers want to invest in DTx now?
  3. What must happen next for DTx tools to become key components of how diseases are managed and treated?

WHAT’S IN THIS REPORT? How DTx solutions differ from typical digital health products and the opportunity they offer, as well as an analysis of the factors that will define success for DTx companies.

KEY STAT: US physicians are willing to prescribe DTx to patients based on their clinical efficacy.

Here’s what’s in the full report


Exportable files for easy reading, analysis and sharing.


Reliable data in simple displays for presentations and quick decision making.

6expert perspectives

Insights from industry and company leaders.

    Table of Contents

    1. Executive Summary
    2. Key Points
    3. Digital Therapeutics Find Their Footing in Healthcare
    1. The Opportunity: Assessing the Value of Digital Therapeutics
    2. What Will Determine DTx Success?
    3. Insider Intelligence Interviews
    1. Read Next
    2. Sources
    3. Media Gallery

    Interviewed for This Report

    Afsana Akhter
    Amelia Virtual Care
    Interviewed March 1, 2022
    Brenda Miao
    Bakar Computational Health Sciences Institute, University of California, San Francisco
    Interviewed February 24, 2022
    Andy Molnar
    Digital Therapeutics Alliance
    Interviewed February 17, 2022
    Marissa Schlueter Moore
    OMERS Ventures
    Health Tech Investor
    Interviewed March 2, 2022
    Santosh Shanbhag
    Akili Interactive
    Interviewed March 14, 2022
    Chris Wasden
    Happify Health
    Head of Pharma Specialty Solutions and Corporate Strategy
    Interviewed March 3, 2022

    Access full deck

    View a slide-show representation of this report’s key insights, where carefully vetted data is combined with industry trend analysis, included at no extra cost.
    Download PPTX











    Access All Charts and Data

    Gain access to reliable data presented in clear and intelligible displays for quick understanding and decision making on the most important topics related to your industry, included at no extra cost.


    Rajiv Leventhal


    Eleni Digalaki
    Principal Analyst
    Jeane Han
    Senior Researcher
    Lisa Phillips
    Principal Analyst, Digital Health